Asia-Pacific Synthetic Biology Market

Asia-Pacific Synthetic Biology Market Size, Share & Trends Analysis Report, By Product (Enabling Product, Core Product, and Enabled Product), By Technologies (Gene Synthesis & Sequencing, Genome Engineering, Bioinformatics, and Others), By Application (Medical Application, Industrial Application, Food & Agriculture, and Environmental Applications) and Forecast Period 2019-2025
    Update Available - Forecast 2024-2030   

Published: Feb 2020 | Report Code: OMR2021051 | Category : Biotechnology | Delivery Format: /

The Asia-Pacific synthetic biology market is expected to grow at a CAGR of 35.0% during the forecast period. The initiatives by major economies in the field of synthetic biology is one of the factors that is promoting technological innovations in the Asia-Pacific region. China is investing in the synthetic biology driven by a coordinated national strategy under state sponsored programs. This result in growth in number of journal publications, for instance, in 2013 out of total papers published on synthetic biology 10% were from China. 

Visit for Global Synthetic Biology Market Report at: https://www.omrglobal.com/industry-reports/synthetic-biology-market-size

The other countries such as India, Japan and South Korea are rapidly developing vibrant synthetic biology communities, supported by national institutes on synthetic biology. This institutes generating research outputs that significantly contributing to the advancements in the synthetic biology. In October 2017, Australia and China symposium on synthetic biology was held to facilitate stronger collaborative ties between two countries by making Australia-China Science and Research Fund (ACSRF).

The Asia-Pacific synthetic biology market is segmented on the basis of product, technology, and applications. Based on the product, the market is segmented into enabling product, core product, and enabled product. Core product includes synthetic genes, synthetic cells, synthetic DNA, chassis organisms and xeno nucleic acid (XNA), and are expected to hold a significant share in the market owing to extensive use of core products in R&D. Based on technology, the market is segmented into, and gene synthesis & sequencing, genome engineering, bioinformatics, and others. Based on application, the market is segmented into medical application, industrial application, food & agriculture, and environmental applications.

Moreover, the study of the report covers the competitive analysis of various players operating in the Asia-Pacific synthetic biology market. Some of the key players in the Asia-Pacific synthetic biology market include Twist Bioscience Corp., Merck KGaA, GenScript Biotech Corp., Thermo Fisher Scientific Inc., Amyris Inc., Codexis Inc, Ginkgo Bioworks, and many others.

Research Methodology

The market study of the Asia-Pacific synthetic biology is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include

  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for pharmaceutical companies, drug manufacturers, biotechnology companies, chemical and biofuel industry, academic and government research institutes, food and agriculture industries, potential investors and venture capitalists, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, products offered by the company, and future market opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation

1. Asia-Pacific Synthetic Biology Market Research and Analysis by Product.

2. Asia-Pacific Synthetic Biology Market Research and Analysis by Technology. 

3. Asia-Pacific Synthetic Biology Market Research and Analysis by Application.

The Report Covers

  • Comprehensive research methodology of the Asia-Pacific synthetic biology market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Asia-Pacific synthetic biology market.
  • Insights about market determinants which are stimulating the Asia-Pacific synthetic biology market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

1. Report Summary

1.1. Research Methods and Tools

1.2. Market Breakdown

1.2.1. By Segments

1.2.2. By Geography

2. Market Overview and Insights

2.1. Scope of the Report

2.2. Analyst Insight & Current Market Trends

2.2.1. Key Findings

2.2.2. Recommendations

2.2.3. Conclusion

2.3. Rules & Regulations

3. Competitive Landscape

3.1. Company Share Analysis

3.2. Key Strategy Analysis

3.3. Key Company Analysis

3.3.1. Overview

3.3.2. Financial Analysis

3.3.3. SWOT Analysis

3.3.4. Recent Developments

4. Market Determinants 

4.1. Motivators

4.2. Restraints

4.3. Opportunities 

5. Market Segmentation

5.1. Asia-Pacific Synthetic Biology Market by Product

5.1.1. Enabling Product

5.1.2. Core Product

5.1.3. Enabled Product

5.2. Asia-Pacific Synthetic Biology Market by Technology

5.2.1. Gene Synthesis & Sequencing

5.2.2. Genome Engineering

5.2.3. Bioinformatics

5.2.4. Others

5.3. Asia-Pacific Synthetic Biology Market by Application 

5.3.1. Medical Application

5.3.2. Industrial Application

5.3.3. Food & Agriculture

5.3.4. Environmental Application

6. Regional Analysis

6.1. China

6.2. India

6.3. Japan

6.4. Rest of Asia-Pacific

7. Company Profiles

7.1. Autolus Therapeutics PLC

7.2. Butamax Advanced Biofuels LLC

7.3. Desktop Genetics, Ltd.

7.4. E. I. du Pont de Nemours and Co.

7.5. GenScript Biotech Corp.

7.6. Ginkgo Bioworks (The Organism Co)

7.7. Integrated DNA Technologies, Inc.

7.8. LGC, Ltd.

7.9. Merck KGaA

7.10.  Thermo Fisher Scientific, Inc.

7.11.  Twist Bioscience Corp.

1. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)

2. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)

3. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)

4. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)


1.  ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SHARE BY PRODUCT, 2018 VS 2025 (%)

2. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SHARE BY TECHNOLOGY, 2018 VS 2025 (%)

3. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)

4. INDIA SYNTHETIC BIOLOGY MARKET SIZE, 2018-2025 ($ MILLION)

5. CHINA SYNTHETIC BIOLOGY MARKET SIZE, 2018-2025 ($ MILLION)

6. JAPAN SYNTHETIC BIOLOGY MARKET SIZE, 2018-2025 ($ MILLION)

7. REST OF ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, 2018-2025 ($ MILLION)